Pharmacy

For   new   biologicals and   biosimilars, the innovative Spedia NMR™ technology from Spinnovation Biologies provides a real advantage for optimizing cell cultures, monitoring and standardizing manufacturing processes in preparation for larger scale production. Within the past four months, this has been validated by 37 companies developing biologies or delivering services to this industry.

This premium Nuclear Magnetic Resonance (NMR) analysis service rapidly identifies a wide selection of feed components, metabolites and toxic compounds in culture media. By comparing media profiles from different cell culture batches, Spedia-NMR™ identifies how a cell consumes and metabolizes the media along the culture process. This allows the composition of the media to be fine-tuned to improve cell viability, reach highest yields of biologic product and perform rapid process troubleshooting. Talking about the value of Spedia-NMR™ in biotech companies, Dr Frederic Girard, CEO, Spin ovation, explained, "In a short term, Spedia-NMR™ will fill the gap in knowledge to strengthen and speed up cell culture development and upstream processing. Clients need to know what is going on in their cell culture and they need to know it fast." This technology is available on a fee-for-sample or as a contract service to all biotech companies.